HIV

;

Federal Government Issues Guidance to Insurers on Coverage of HIV Prevention Drugs

Jul 19, 2021

Today, the federal government issued guidance to insurers to remind them of their obligation to cover pre-exposure prophylaxis (PrEP), which are drugs that prevent HIV, at no cost to their beneficiaries. The guidance, in the form of an FAQ, also clarifies that associated services with PrEP, such as provider visits and HIV, hepatitis, and STD testing along with other laboratory tests, must also be covered with no patient cost-sharing. This follows previous guidance for the coverage of other preventive services that have associated services and costs, such as colonoscopies.

read more

House Supports Significant Funding Increases for Domestic HIV Programs: Minimal Increase for Hepatitis Programs

Jul 14, 2021

The US House of Representatives is proposing to significantly increase funding to continue to ramp up efforts to end HIV in the United States. In addition to an increase of $245 million for domestic HIV testing, prevention, and treatment programs as part of the Ending the HIV Epidemic initiative, which matches the amount proposed in President Joe Biden’s budget, the Appropriations Committee in its FY22 Labor, HHS appropriations bill is proposing an $146 million increase to the Ryan White HIV/AIDS Program, (+$100 million over Biden’s budget) and $190 million more for NIH AIDS Research that was not included in the president’s budget. The House is only including an increase of $5 million for CDC’s hepatitis division for a total of $44.5 million.

read more

Biden Budget Proposes Increased Funding for Ending HIV

May 28, 2021

Washington DC… In President Biden’s first preliminary budget that was released today, he is proposing to continue to ramp up efforts to end HIV in the United States with an increase of $267 million for domestic HIV testing, prevention, and treatment programs as part of the Ending the HIV Epidemic Initiative.

read more

Biden budget proposes increased funding for ending HIV

Apr 9, 2021

Washington DC… In President Biden’s first preliminary budget that was released today, he is proposing to continue to ramp up efforts to end HIV in the United States with an increase of $267 million for domestic HIV testing, prevention, and treatment programs as part of the Ending the HIV Epidemic Initiative.

read more

Biden administration pulls last-minute Trump Medicare drug demo plan

Mar 16, 2021

Washington DC… In a victory for patients who depend on Medicare Part D for their medications, the Biden administration has pulled a demonstration project that would have allowed participating Medicare plans in 2022 to not cover all drugs in certain classes and only one drug per class in all others. The proposal that was pulled was announced literally in the final hours of the Trump administration.

read more

Search

Press Release Tags

ACA Appropriations Biden administration CDC Congress Copay accumulators Copay assistance Cost-sharing COVID-19 Drug Pricing FDA Gay men healthcare Hepatitis Hepatitis B Hepatitis C hepatits HIV HIV Prevention hous housing insurer Insurers LGBT Medicaid Medicare Part D NAIC NIH PBMs PrEP Prescription Drugs prevention Private Insurance Ryan White Ryan White Program state Syringe services Testing transparency Treatment Trump administration

Recent Press Releases

Pin It on Pinterest